Loading company…
Qianglian Zhichuang develops software and services for diagnosing and treating cerebrovascular diseases.
Founded in 2016 and based in Beijing, Qianglian Zhichuang provides diagnostic and treatment tools for hemorrhagic and ischemic stroke, including software for aneurysm surgery planning and risk assessment. It also offers clinical research and trial services. In October 2024, it raised approximately CNY 100 million in Series D+ funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Qianglian Zhichuang (Beijing) Technology Co., Ltd.? This is my company